Visit us at Medica, Dusseldorf, Germany 17-20 November 2025 at Hall 16, Stand D17-5 and ask us about our free AI tools and the document builder.
Pure Global

ANTI-INFLIXIMAB (IFX) ANTIBODIES - ANVISA Registration 80102512585

Access comprehensive regulatory information for ANTI-INFLIXIMAB (IFX) ANTIBODIES in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 80102512585 and manufactured by manufacturer not specified. The registration is held by VR MEDICAL IMPORTADORA E DISTRIBUIDORA DE PRODUTOS Mร‰DICOS LTDA with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 3 companies making the same product including BODITECH MED INC., PROGENIKA BIOPHARMA S.L., and 4 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
3 Competitors
4 Recent Registrations
80102512585
Registration Details
ANVISA Registration Number: 80102512585
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Free consultation

Device Details

Quantum Blueยฎ Anti-Infliximab
Risk Class II

Registration Details

80102512585

25351972539202065

04718143000194

Dates and Status

Sep 24, 2020

VIGENTE

09/18/2025 19:00:01

Companies Making Similar Products
Top companies providing products with the same technical name: "ANTI-INFLIXIMAB (IFX) ANTIBODIES"